Nielsen H, Rossi M, Martínez F. "一种的合成方法" [P]. European Patent, EP 3399031 A1, 2019-03-28.
发明人冯建国,林芳,沈红梅. "Method for the Synthesis of 1-benzyl-5-chloro-N-methyl-2-oxo-N-phenyl-1,2-dihydro-3-pyridinecarboxamide
339024-44-1
KS-00003E21" [P]. 中国发明专利, 专利号 CN 115752357 B, 授权公告日 2022-06-27.
Schröder R, Hughes D C, Fischer A B. "A Process for Preparing High-Purity 1-benzyl-5-chloro-N-methyl-2-oxo-N-phenyl-1,2-dihydro-3-pyridinecarboxamide
339024-44-1
KS-00003E21" [P]. US Patent, US 11425466 B2, 2019-07-23.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2021, 1834, (8), 6272-6299.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2013, 1194, (4), 8308-8328.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 1-benzyl-5-chloro-N-methyl-2-oxo-N-phenyl-1,2-dihydro-3-pyridinecarboxamide
339024-44-1
KS-00003E21 Using HRMS and NMR". Talanta, 2018, 390, (7), 8946-8959.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2015, 315, (8), 1782-1796.